Evofem Biosciences, Inc. (EVFM) Balance Sheet Quarterly

Evofem Biosciences, Inc.

EVFM (OTC)

(%)

Financials
Evofem Biosciences, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q4) 12-31	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30
Report Filing:	2026-03-11	2025-11-13	2025-08-14	2025-05-15	2025-03-24	2024-11-14	1234
Total Current Assets	15.28	7.92	8.97	5.87	13.61	8.58	1234
Cash and Short Term Investments	0.578	0.84	0.748	0.221	0.741	0.202	1234
Cash & Equivalents	0.578	0.84	0.748	0.221	0.741	0.722	1234
Short Term Investments	0	0	0.125	0	0	0.202	1234
Receivables	12.48	4.43	4.93	1.15	9.83	5.39	1234
Inventory	1.13	1.68	1.91	2.26	1.58	1.46	1234
Other Current Assets	1.1	0.959	1.38	2.24	1.46	1.52	1234
Total Assets	20.27	13.81	14.38	12.88	23.79	23.94	1234
Total Non-Current Assets	4.99	5.89	5.41	7	10.18	15.37	1234
Property, Plant and Equipment	0.6	0.615	0.638	0.481	0.547	1.31	1234
Goodwill and Intangible Assets	4.35	5.24	4.74	6.49	9.6	14.02	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	4.35	5.24	4.74	6.49	9.6	14.02	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	0.042	0.036	0.036	0.036	0.036	0.036	1234
Total Current Liabilities	84.82	78.19	73.89	70.85	80.45	76.29	1234
Accounts Payable	13.15	11.62	12.29	11.22	16.17	16.86	1234
Notes Payable/Short Term Debt	65.81	64.87	47.22	45.72	45.96	44.77	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	0	0	0	0	0	0	1234
Other Current Liabilities	5.85	1.69	14.38	13.91	18.32	14.65	1234
Total Liabilities	89.71	83.98	84	82.46	95.05	90.07	1234
Total Non-Current Liabilities	4.89	5.79	10.11	11.61	14.6	13.79	1234
Total Long Term Debt	0.054	0.072	0.089	0.005	0.007	0.01	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	0.054	0.196	0.213	0.053	0.089	0.126	1234
Other Long Term Liabilities	4.78	5.52	9.8	11.55	14.5	13.65	1234
Total Equity	-69.44	-70.17	-69.62	-69.59	-71.26	-66.13	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	-69.44	-70.17	-69.62	-69.59	-71.26	-66.13	1234
Retained Earnings	-897.4	-900.2	-898.5	-896.7	-897.7	-894.6	1234
Accumulated Other Earnings	-8.82	-6.72	-2.56	-1.98	-2.63	-1.71	1234
Common Stock	0.013	0.012	0.012	0.011	0.011	0.01	1234
Preferred Stock	4.9	4.9	4.79	0	0	4.76	1234
Additional Paid in Capital	831.9	831.8	831.4	829.1	829	825.4	1234
Total Liabilities & Total Equity	20.27	13.81	14.38	12.88	23.79	23.94	1234
Total Liabilities & Shareholders' Equity	20.27	13.81	14.38	12.88	23.79	23.94	1234
Total Investments	0	0	0.125	0	0	0.202	1234
Total Debt	65.87	64.82	47.31	45.73	45.97	44.78	1234
Net Debt	65.29	63.98	47.31	45.51	45.97	44.78	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Evofem Biosciences, Inc. Balance Sheet Statement Quarterly